Table 1

Details of the 15 patients with secondary progressive multiple sclerosis that consented to lumbar punctures before and after alemtuzumab treatment

No of patients15
No of females (%)10 (67)
Age at time of treatment (years) (median (range))40 (23–49)
Disease duration (years) (median (range))4 (1–13)
EDSS pretreatment (median (range))6 (4–7)
Time of pretreatment LP (days) (median (range))1 (0–37)
Time of post-treatment LP (months) (median (range))11 (3–28)
  • EDSS, Expanded Disability Status Score; LP, lumbar puncture.